238 related articles for article (PubMed ID: 23377332)
1. Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications.
Rzany B; Fratila AA; Fischer TC; Hilton S; Pavicic T; Rothhaar A; Sattler G; Sommer B; Pickett A
J Drugs Dermatol; 2013 Jan; 12(1):80-4. PubMed ID: 23377332
[TBL] [Abstract][Full Text] [Related]
2. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part II: Wrinkles on the middle and lower face, neck and chest.
Ascher B; Talarico S; Cassuto D; Escobar S; Hexsel D; Jaén P; Monheit GD; Rzany B; Viel M
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1285-95. PubMed ID: 20569284
[TBL] [Abstract][Full Text] [Related]
3. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part I: Upper facial wrinkles.
Ascher B; Talarico S; Cassuto D; Escobar S; Hexsel D; Jaén P; Monheit GD; Rzany B; Viel M
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1278-84. PubMed ID: 20337830
[TBL] [Abstract][Full Text] [Related]
4. Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview.
Rzany B; Ascher B; Monheit G
J Eur Acad Dermatol Venereol; 2010 Jan; 24 Suppl 1():1-14. PubMed ID: 19930409
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin injection for facial wrinkles.
Small R
Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
Dessy LA; Fallico N; Mazzocchi M; Scuderi N
Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A for aging face and aesthetic uses.
Hexsel C; Hexsel D; Porto MD; Schilling J; Siega C
Dermatol Ther; 2011; 24(1):54-61. PubMed ID: 21276158
[TBL] [Abstract][Full Text] [Related]
8. Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendations.
Kane M; Donofrio L; Ascher B; Hexsel D; Monheit G; Rzany B; Weiss R
J Drugs Dermatol; 2010 Jan; 9(1 Suppl):s7-22; quiz s23-5. PubMed ID: 20919448
[TBL] [Abstract][Full Text] [Related]
9. Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration.
Nestor M; Ablon G; Pickett A
Aesthet Surg J; 2017 May; 37(suppl_1):S20-S31. PubMed ID: 28388717
[TBL] [Abstract][Full Text] [Related]
10. The evolution of botulinum neurotoxin type A for cosmetic applications.
Carruthers J; Carruthers A
J Cosmet Laser Ther; 2007 Sep; 9(3):186-92. PubMed ID: 17763029
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of type A botulinum toxins for aesthetic indications and their relative economic impact.
Jandhyala R
J Plast Reconstr Aesthet Surg; 2012 Jun; 65(6):720-31. PubMed ID: 22225675
[TBL] [Abstract][Full Text] [Related]
12. Overview of botulinum neurotoxins.
Lowe NJ
J Cosmet Laser Ther; 2007; 9 Suppl 1():11-6. PubMed ID: 17885881
[TBL] [Abstract][Full Text] [Related]
13. Italian consensus report on the aesthetic use of onabotulinum toxin A.
Bertossi D; Cavallini M; Cirillo P; Piero Fundarò S; Quartucci S; Sciuto C; Tonini D; Trocchi G; Signorini M
J Cosmet Dermatol; 2018 Oct; 17(5):719-730. PubMed ID: 30091253
[TBL] [Abstract][Full Text] [Related]
14. Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study.
Molina B; Grangier Y; Mole B; Ribe N; Martín Diaz L; Prager W; Paliargues F; Kerrouche N
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1382-8. PubMed ID: 25495499
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin: examining duration of effect in facial aesthetic applications.
Flynn TC
Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
[TBL] [Abstract][Full Text] [Related]
16. Advances in the use of botulinum neurotoxins in facial esthetics.
Flynn TC
J Cosmet Dermatol; 2012 Mar; 11(1):42-50. PubMed ID: 22360334
[TBL] [Abstract][Full Text] [Related]
17. Consensus recommendations on the aesthetic usage of botulinum toxin type A in Asians.
Ahn BK; Kim YS; Kim HJ; Rho NK; Kim HS
Dermatol Surg; 2013 Dec; 39(12):1843-60. PubMed ID: 24118218
[TBL] [Abstract][Full Text] [Related]
18. Clinical resistance to three types of botulinum toxin type A in aesthetic medicine.
Stephan F; Habre M; Tomb R
J Cosmet Dermatol; 2014 Dec; 13(4):346-8. PubMed ID: 25399628
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines.
Moy R; Maas C; Monheit G; Huber MB;
Arch Facial Plast Surg; 2009; 11(2):77-83. PubMed ID: 19289677
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid filler and botulinum Neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy.
Kenner JR
J Drugs Dermatol; 2010 Sep; 9(9):1135-8. PubMed ID: 20865847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
